GLP-1 Pipeline In November 2023, the FDA approved Zepbound (tirzepatide), a GLP-1 antagonist and GIP dual agonist with superior weight loss efficacy compared to its competitors
In 1846 he demonstrated that when there is an excess of glucose in the blood it gets captured by the liver and stored there as a white starchy substance he called 'glycogen', which the liver turned back into glucose when glucose levels in blood got too low (Karamanou Protogerous Tsoucalas
Pros: Strong average weight loss results Weekly injection schedule Helps regulate appetite throughout the day May improve blood sugar levels Often effective for obesity and overweight patients Cons: Common side effects include nausea, constipation, and diarrhea Can feel expensive without insurance Some people experience fatigue early on Not recommended for people with a family history of medullary thyroid carcinoma 2
Once MC1R receptors are saturated at 0.751.0mg, additional peptide does not accelerate tanning it simply increases systemic exposure and side effect probability without research benefit
Two of the most widely discussed prescription weight loss injections are semaglutide and tirzepatide
Guerrant RL, Steiner TS, Lima AA, Bobak DA (1999) How intestinal bacteria cause disease